Actemra 162 mg/0.9 mL ACTPen® autoinjector Images
Generic Name: tocilizumab
This medication has been identified as Actemra 162 mg/0.9 mL ACTPen® autoinjector and is used for Giant Cell Arteritis, COVID-19, Rheumatoid Arthritis, Cytokine Release Syndrome, and Polyarticular Juvenile Idiopathic Arthritis. It belongs to the drug class interleukin inhibitors and is not a controlled substance.
Images of medication
Actemra
- Generic Name
- tocilizumab
- Strength
- 162 mg/0.9 mL ACTPen® autoinjector
- Availability
- Prescription only
- Drug Class
- Interleukin inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Genentech, Inc.
- National Drug Code (NDC)
- 50242-0143
See also:
More about Actemra (tocilizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (49)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.